Prevention of transfusion reactions with washed platelet concentrates

Prevention of transfusion reactions with washed platelet concentrates - Prevention of transfusion reactions with washed PC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003187

Enrollment

Registered

2010-02-16

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological diseases

Interventions

washed PC non-washed PC

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient with hematological diseases who has experienced transfusion reactions more than two times. 2. Patient who agrees with this study. 3. Patient who has not have serious complications in heart, kidney, or liver or infections. 4. Patient who was assessed eligible for this study by doctors.

Exclusion criteria

Exclusion criteria: 1. Patient who experienced serious advanced reactions including anaphylactic reactions. 2. Patinet who has PC transfusion refractoriness. 3. Patient who uses steroid and antihistamine agents regularly. 4. Patient who was assessed ineligible for this study by doctors.

Design outcomes

Primary

Measure	Time frame
Decrease in incidence of transfusion reactions with washed PC	—

Countries

Japan

Contacts

Public ContactMotoaki Uruma

Aichi Medical University Hospital Transfusion medicine

uruma@aichi-med-u.ac.jp0561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026